NASDAQ: ATRA
Atara Biotherapeutics Inc Stock Ownership - Who owns Atara Biotherapeutics?

Insider buying vs selling

Have Atara Biotherapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Anhco NguyenPresident and CEO2024-11-181,664$11.20
$18.63kSell
Jill HenrichEVP Chief Regulatory Officer2024-11-181,000$11.20
$11.20kSell
Eric J. HyllengrenEVP CFO and COO2024-11-181,364$11.20
$15.27kSell
Pascal TouchonPresident and CEO2024-08-162,762$6.63
$18.31kSell
Jill HenrichEVP Global Head RA Quality2024-08-16132$6.63
$875.29Sell
Jill HenrichEVP Global Head RA Quality2024-08-16831$6.63
$5.51kSell
Eric J. HyllengrenEVP CFO2024-08-1629$6.63
$192.30Sell
Eric J. HyllengrenEVP CFO2024-08-161,041$6.63
$6.90kSell
Amar MuruganEVP Chief Legal Officer2024-08-1689$6.63
$590.16Sell
Amar MuruganEVP Chief Legal Officer2024-08-16192$6.63
$1.27kSell

1 of 3

ATRA insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when ATRA insiders and whales buy or sell their stock.

ATRA Shareholders

What type of owners hold Atara Biotherapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Domain Partners VIII LP37.18%2,141,542$18.40MInsider
Adiumentum Capital Fund I LP19.69%1,133,823$9.74MInsider
Joel S. Marcus15.62%899,855$7.73MInsider
Carol Giltner Gallagher12.02%692,264$5.95MInsider
Isaac E. Ciechanover10.82%622,930$5.35MInsider
Eric Dobmeier9.78%563,325$4.84MInsider
Ecor1 Capital LLC9.24%532,134$4.57MInstitution
William K. Heiden6.23%359,000$3.08MInsider
Jakob Dupont5.05%290,794$2.50MInsider
Charlene A. Banard4.79%276,010$2.37MInsider

1 of 3

ATRA vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ATRA12.38%87.62%Net SellingNet Selling
ALVR10.18%89.82%Net SellingNet Selling
BOLD31.75%23.91%Net Buying
DYAI8.77%91.23%Net BuyingNet Buying
XLO40.96%59.04%Net BuyingNet Buying

Atara Biotherapeutics Stock Ownership FAQ

Who owns Atara Biotherapeutics?

Atara Biotherapeutics (NASDAQ: ATRA) is owned by 24.18% institutional shareholders, 171.17% Atara Biotherapeutics insiders, and 0.00% retail investors. Domain Partners VIII LP is the largest individual Atara Biotherapeutics shareholder, owning 2.14M shares representing 37.18% of the company. Domain Partners VIII LP's Atara Biotherapeutics shares are currently valued at $18.40M.

If you're new to stock investing, here's how to buy Atara Biotherapeutics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.